Please provide your email address to receive an email when new articles are posted on . Earlier initiation of donanemab reduced the risk of disease progression on the Clinical Dementia Rating-Global ...
Recent Food and Drug Administration approval of the first two blood tests used in detecting Alzheimer’s disease brings hope ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback